Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) EBT Margin (2016 - 2025)

Mimedx (MDXG) has disclosed EBT Margin for 15 consecutive years, with 18.46% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 635.0% to 18.46% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 15.83% through Dec 2025, down 59.0% year-over-year, with the annual reading at 15.83% for FY2025, 59.0% down from the prior year.
  • EBT Margin hit 18.46% in Q4 2025 for Mimedx, down from 20.09% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 26.62% in Q2 2024 to a low of 17.7% in Q1 2022.
  • Historically, EBT Margin has averaged 5.55% across 5 years, with a median of 11.42% in 2023.
  • Biggest five-year swings in EBT Margin: tumbled -1354bps in 2022 and later soared 2745bps in 2023.
  • Year by year, EBT Margin stood at 0.18% in 2021, then surged by 7301bps to 13.25% in 2022, then rose by 21bps to 16.02% in 2023, then fell by -24bps to 12.11% in 2024, then skyrocketed by 52bps to 18.46% in 2025.
  • Business Quant data shows EBT Margin for MDXG at 18.46% in Q4 2025, 20.09% in Q3 2025, and 13.19% in Q2 2025.